Barclays Boosts Colgate-Palmolive (NYSE:CL) Price Target to $74.00

Colgate-Palmolive (NYSE:CLGet Rating) had its price target boosted by Barclays from $71.00 to $74.00 in a report released on Tuesday, Benzinga reports. The brokerage currently has an equal weight rating on the stock.

CL has been the subject of a number of other research reports. StockNews.com raised shares of Colgate-Palmolive from a hold rating to a buy rating in a report on Tuesday. Deutsche Bank Aktiengesellschaft lowered their price target on shares of Colgate-Palmolive from $88.00 to $87.00 in a research report on Tuesday, July 19th. Atlantic Securities downgraded shares of Colgate-Palmolive from an overweight rating to a neutral rating and reduced their price target for the company from $92.00 to $80.00 in a research note on Tuesday, May 3rd. UBS Group upped their target price on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the stock a buy rating in a research note on Monday. Finally, Stifel Nicolaus lowered their price target on shares of Colgate-Palmolive from $90.00 to $88.00 in a report on Wednesday, April 13th. Twelve equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, Colgate-Palmolive has an average rating of Hold and an average price target of $84.57.

Colgate-Palmolive Price Performance

Shares of CL stock opened at $80.89 on Tuesday. The company has a debt-to-equity ratio of 14.26, a current ratio of 1.17 and a quick ratio of 0.72. The company has a market capitalization of $67.47 billion, a P/E ratio of 35.02, a P/E/G ratio of 5.75 and a beta of 0.48. The company’s 50-day simple moving average is $78.34 and its two-hundred day simple moving average is $78.34. Colgate-Palmolive has a one year low of $72.20 and a one year high of $85.61.

Colgate-Palmolive (NYSE:CLGet Rating) last released its quarterly earnings data on Friday, July 29th. The company reported $0.72 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.01. The firm had revenue of $4.48 billion for the quarter, compared to the consensus estimate of $4.35 billion. Colgate-Palmolive had a net margin of 10.98% and a return on equity of 315.10%. The company’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period last year, the firm earned $0.80 earnings per share. As a group, equities analysts anticipate that Colgate-Palmolive will post 3.03 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, August 15th. Shareholders of record on Thursday, July 21st will be given a dividend of $0.47 per share. The ex-dividend date is Wednesday, July 20th. This represents a $1.88 dividend on an annualized basis and a yield of 2.32%. Colgate-Palmolive’s payout ratio is currently 81.39%.

Insiders Place Their Bets

In other Colgate-Palmolive news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, June 6th. The shares were sold at an average price of $79.34, for a total transaction of $3,967,000.00. Following the completion of the transaction, the chief executive officer now owns 221,790 shares in the company, valued at approximately $17,596,818.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, VP Philip G. Shotts sold 10,000 shares of the stock in a transaction dated Monday, May 16th. The shares were sold at an average price of $78.52, for a total value of $785,200.00. Following the completion of the transaction, the vice president now owns 46,094 shares in the company, valued at approximately $3,619,300.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction dated Monday, June 6th. The shares were sold at an average price of $79.34, for a total transaction of $3,967,000.00. Following the completion of the transaction, the chief executive officer now owns 221,790 shares of the company’s stock, valued at approximately $17,596,818.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 79,683 shares of company stock worth $6,297,119. 0.32% of the stock is owned by insiders.

Institutional Investors Weigh In On Colgate-Palmolive

A number of large investors have recently added to or reduced their stakes in CL. Centaurus Financial Inc. boosted its position in shares of Colgate-Palmolive by 9.3% in the fourth quarter. Centaurus Financial Inc. now owns 4,199 shares of the company’s stock worth $358,000 after acquiring an additional 357 shares during the last quarter. Capital Investment Advisory Services LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $254,000. FDx Advisors Inc. boosted its position in shares of Colgate-Palmolive by 93.8% in the fourth quarter. FDx Advisors Inc. now owns 12,160 shares of the company’s stock worth $1,038,000 after acquiring an additional 5,886 shares during the last quarter. AGF Investments Inc. acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $249,000. Finally, Dixon Hughes Goodman Wealth Advisors LLC acquired a new stake in shares of Colgate-Palmolive in the fourth quarter worth approximately $88,000. 78.12% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.